
Transactions: Sweden
Filter


Initial public offering of BioInvent International AB (SE) — SEK 372 million

Divestment of Entific Medical Systems (SE) to Cochlear (AU) by CapMan, Investor Growth Capital and Nobel Biocare (SE) — SEK 1,050 million

New share issue in Biotage AB (SE) — SEK 34 million

Directed new share issue in Oasmia Pharmaceutical AB (SE) — SEK 48 million

Redemption in Castellum (SE) — SEK 700 million

Redemption offer in JM (SE) — SEK 1 billion


Merger of Sparbanken (SE) and Föreningsbanken (SE) — SEK 43 billion

Convertible bond issue in Bluefish Pharmaceuticals (SE) — SEK 60 million

Secured bond issue by Svensk FastighetsFinansiering II AB (SE) — SEK 1.25 billion

Divestment by Skandia (SE) of Vesta Skadeforsikring (NO) and Vesta Liv (NO) to Tryg-Baltica (DK) — NOK 5.1 billion
